Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Cephalosporin analogue
Sirtuin inhibitor and iron chelator.
Fetal hemoglobin stimulator; ribonucleotide red...
Prenylated flavonoid found in Humulus lupulus.<...
5-HT1A partial agonist, SERT inhibitor.
SIRT1/2 inhibitor, indirect p53 activator.
Diterpenoid epoxide found in Tripterygium.
Isoflavone, phytoestrogen found in soy; ER agon...
Endogenous peptide, involved in vasoconstrictio...
Peptide, substance P analog; NK agonist.
Viral M2 proton channel blocker.
Cysteine-ITC conjugate, antioxidant.
Furanolactone found in citrus fruits.
Polyketide; protein translation inhibitor, mamm...
JAK1/2/3 inhibitor.
β2-adrenergic agonist.
Pyramido-pyrrolo-quinoxalinedione; CFTR blocker...
Dynamin inhibitor.
Endogenous peptide, involved in vascular contra...
5-HT3 antagonist.